Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Artificial Intelligence Could Predict Chest Tube Drainage Necessity for Spontaneous Pneumothorax.

Journal of imaging informatics in medicine·2026

Same author

Trends and Survival Outcomes of Lung Cancer Surgery in South Korea, 2015-2019.

Thoracic cancer·2026

Same author

A narrative review of segmentectomy versus lobectomy in elderly patients with early-stage NSCLC: challenging the longstanding standard.

Translational cancer research·2025

Same author

Mental health of medical students who took a leave of absence during the 2024 medical crisis in South Korea.

BMC public health·2025

Same author

Comparative evaluation of ultrafiltration membranes for exosome isolation from A549 cell-conditioned medium.

Preparative biochemistry & biotechnology·2025

Same author

Runx3 Restoration Regresses K-Ras-Activated Mouse Lung Cancers and Inhibits Recurrence.

Cells·2023

Search research articles

Related Experiment Video

Updated: May 27, 2026

Generation of Tumor Organoids from Genetically Engineered Mouse Models of Prostate Cancer

Generation of Tumor Organoids from Genetically Engineered Mouse Models of Prostate Cancer

Published on: June 13, 2019

Organoids in Cancer Research: Current Applications, Limitations, and Technological Advances.

Sujeong Kim¹, Se Eun Park^1,2, Chanwoo Kim^1,2

¹DK lab, Chungbuk National University and Chungbuk National University Hospital, Cheongju, Korea.

Journal of Chest Surgery

|May 26, 2026

Summary

Patient-derived tumor organoids offer a powerful preclinical cancer research platform, advancing precision medicine by predicting drug responses. Ongoing research aims to improve their physiological relevance by incorporating tumor microenvironment components.

Keywords:

Organoids Precision medicine Surgery Tumor microenvironment

More Related Videos

Establishment of Pancreatic Cancer-Derived Tumor Organoids and Fibroblasts From Fresh Tissue

Establishment of Pancreatic Cancer-Derived Tumor Organoids and Fibroblasts From Fresh Tissue

Published on: May 26, 2023

Establishment and Histological Analysis of Esophageal Organoids Modeling the Progression from Normal to Cancerous Tissues

Establishment and Histological Analysis of Esophageal Organoids Modeling the Progression from Normal to Cancerous Tissues

Published on: May 30, 2025

Related Experiment Videos

Last Updated: May 27, 2026

Generation of Tumor Organoids from Genetically Engineered Mouse Models of Prostate Cancer

Generation of Tumor Organoids from Genetically Engineered Mouse Models of Prostate Cancer

Published on: June 13, 2019

Establishment of Pancreatic Cancer-Derived Tumor Organoids and Fibroblasts From Fresh Tissue

Establishment of Pancreatic Cancer-Derived Tumor Organoids and Fibroblasts From Fresh Tissue

Published on: May 26, 2023

Establishment and Histological Analysis of Esophageal Organoids Modeling the Progression from Normal to Cancerous Tissues

Establishment and Histological Analysis of Esophageal Organoids Modeling the Progression from Normal to Cancerous Tissues

Published on: May 30, 2025

Area of Science:

Biomedical Engineering
Cancer Research
Stem Cell Biology

Background:

Organoids are 3D cell cultures from stem cells, mimicking tissue structure and function.
Patient-derived tumor organoids retain primary tumor characteristics, aiding precision medicine.
Current limitations include incomplete tumor microenvironment reconstruction and poor vascularization.

Purpose of the Study:

To review recent advancements in tumor organoid research.
To highlight strategies for enhancing the physiological relevance of tumor organoids.
To discuss future applications in precision oncology and regenerative medicine.

Main Methods:

Review of recent literature on tumor organoid development and applications.
Analysis of innovative approaches like immune cell co-culture and organoid-on-a-chip systems.
Discussion of challenges and future directions in the field.

Main Results:

Tumor organoids serve as effective preclinical models for cancer research.
Patient-derived organoids enable prediction of patient-specific drug responses.
Emerging technologies are addressing limitations in recreating the tumor microenvironment and vascularization.

Conclusions:

Tumor organoids are crucial for advancing precision oncology and personalized medicine.
Continued development is needed to fully replicate the complex tumor microenvironment.
Organoid technology holds promise for regenerative medicine applications.